Professor Xavier Añorve is Q.B.P. graduated from the Faculty of Chemical and Biological Sciences of the Universidad Autónoma de Guerrero (UAGro). He completed his Bachelor's thesis at the Gynecological Cytopathology Laboratory evaluating precursor lesions of cervical cancer (CaCU) with Human Papilloma Virus (HPV) infection and its relationship with markers of tumor progression. Later, he completed a Master's Degree in Biomedical Sciences at the UAGro, at the Laboratory of Molecular Biomedicine, where he completed a thesis on the physical state of the genome of some variants of HPV type 16 in a population of patients with persistent infection by this virus.

He worked in 2014 at Médica Sur Hospital, in the Bioequivalence area as an internal monitor (CIF-BIOTEC). Subsequently, he completed his Ph.D. at the Universidad Autónoma Metropolitana (UAM) Cuajimalpa Campus, in the Postgraduate Course in Natural Sciences and Engineering (PCNI), in the Laboratorio de Biología Celular, where he carried out research work on breast cancer and the development of resistance to radiotherapy regulated by microRNAs and the therapeutic response to other treatments used in this disease.

From 2020 to 2021, he worked as Molecular Diagnostic Coordinator at Laboratorios Liomont, to implement the diagnosis of the SARS-CoV-2 virus by RT-qPCR. Currently, he is attached to the Department of Natural Sciences of the UAM Cuajimalpa Campus, as a part-time professor and belongs to the National System of Researchers (SNI).